The first morbidity/mortality
trial to answer the questions
of antihypertensive treatment
benefits in very elderly hypertensives
General Information Healthcare Professionals Virtual Press Office
Healthcare professionals


   HYVET results

   News
       May 2009
       February 2009

   HYVET videos
       ACC.08 - Hotline
       ACC.08 - Live comments
       ACC.08 - Cardiosource
        Video Network

       Expert Opinions

   HYVET in brief

   More about HYVET
       Rationale
       Study objectives and design
       About indapamide SR
       Study progress
       Investigators' CV
       About Imperial College

   Ancillary studies
       HYVET-COG results

   HYVET slide sets
       Results
       Rationale and design
       HYVET-COG

   HYVET publications

   E-mail alert

DISCLAIMER



Access to this part of the website is intended for the use of Healthcare Professionals only.

By clicking the button "I agree" herebelow, you certify being a Healthcare Professional.
If not, please click on the BACK button




I agree
This website is intended for an international audience. Drug related information may refer to unlicensed products or uses
which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the HYVET study investigators. Site last updated 10 April 2008

To report a suspected side-effect with a Servier drug, please click here.
Contact - 2007 HYVET. All rights reserved